Comprehensive Biomarker Profiling of the IFN-α Pathway in Amyotrophic Lateral Sclerosis Patient Biofluids
NCT07260981
·
clinicaltrials.gov ↗
COMPLETED
Status
60
Enrollment
OTHER
Sponsor class
Conditions
ALS - Amyotrophic Lateral Sclerosis
Sponsor
Ulysses Neuroscience LTD